Bionano Genomics, Inc. (BNGO) vs Retractable Technologies, Inc. (RVP)

Bionano Genomics, Inc. and Retractable Technologies, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. and Retractable Technologies, Inc. are of similar size ($17.6M and $16.1M). Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −11.2%. Retractable Technologies, Inc. has the higher net margin (−10.6% vs −106.6%) and the higher return on invested capital (−42.1% vs −81.7%). Across the 18 metrics below, Retractable Technologies, Inc. leads on 12 and Bionano Genomics, Inc. on 6.

Valuation

Metric BNGO RVP Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 0.48 0.51 2.52
P/B 0.46 0.24 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m 1.47 14.62
EV/Sales 0.72 (0.64) 2.88
Earnings yield (241.60%) (20.69%) (2.67%)
Free cash flow yield (142.62%) (29.42%) 0.09%

Profitability

Metric BNGO RVP Medical Instruments & Supplies median
Gross margin 47.51% (1.45%) 54.29%
Operating margin (106.67%) (66.90%) 1.07%
Net margin (106.58%) (10.62%) (1.61%)
Free cash flow margin (67.87%) (15.07%) 1.08%
Return on equity (83.56%) (4.84%) (1.32%)
Return on assets (52.04%) (2.49%) 0.00%
Return on invested capital (81.68%) (42.05%) 0.00%

Growth

Metric BNGO RVP Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% (11.16%) 8.85%
EPS growth (last fiscal year) 94.50% (7.50%) 8.65%
Revenue growth, 5-year CAGR 27.37% (14.11%) 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO RVP Medical Instruments & Supplies median
Debt to equity 0.11 0.01 0.10
Current ratio 2.48 4.93 2.48
Net debt to EBITDA 1.06 2.69 0.89

Dividend

Metric BNGO RVP Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric BNGO RVP Medical Instruments & Supplies median
Market cap 16.13m 17.61m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack